0001437749-17-016405.txt : 20170927
0001437749-17-016405.hdr.sgml : 20170927
20170927165452
ACCESSION NUMBER: 0001437749-17-016405
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170925
FILED AS OF DATE: 20170927
DATE AS OF CHANGE: 20170927
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hamel Lawrence G
CENTRAL INDEX KEY: 0001511368
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35068
FILM NUMBER: 171104767
MAIL ADDRESS:
STREET 1: C/O ACELRX PHARMACEUTICALS INC.
STREET 2: 575 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001427925
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 351 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-216-3500
MAIL ADDRESS:
STREET 1: 351 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
rdgdoc.xml
FORM 4
X0306
4
2017-09-25
0001427925
ACELRX PHARMACEUTICALS INC
ACRX
0001511368
Hamel Lawrence G
C/O ACELRX PHARMACEUTICALS, INC.
351 GALVESTON DRIVE
REDWOOD CITY
CA
94063
1
Chief Development Officer
Common Stock
2017-09-25
4
S
0
13827
D
68504
I
See footnote
52,125 of the Shares are held in the Hamel Revocable Living Trust
The Shares were sold in a range from $3.50-$4.50
Non-reportable acquisition of 1,977 shares of Common Stock through the Company's Employee Stock Purchase Plan
/s/ Martha Adler, as attorney-in-fact
2017-09-27